Vaccine Scheduler
Poland: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 3 | 4 | 5 | 6 | 7 | 13-15 | 16-18 | 6 | 9 | 14 | 18 | 19 | 59 | 60 | 65 | ≥ 66 | ||||
| RSV | RSV1 | RSV2 | ||||||||||||||||||
| Coronavirus disease (COVID-19) | COVID-193 | |||||||||||||||||||
| tuberculosis | BCG4 | |||||||||||||||||||
| rotavirus infection | ROTA | |||||||||||||||||||
| diphtheria | D | D | D | D | D | d | d | |||||||||||||
| tetanus | TT | TT | TT | TT | TT | TT | TT | |||||||||||||
| pertussis | wcP5 | wcP5 | wcP5 | wcP5 | acP | acp | acp6 | |||||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | IPV | |||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | Hib | ||||||||||||||||
| hepatitis B | HepB4 | HepB | HepB | |||||||||||||||||
| pneumococcal disease | PCV10 or PCV157 | PCV10 or PCV157 | PCV10 or PCV157 | PCV13+PPSV23 | ||||||||||||||||
| meningococcal disease | MCV4/MenB8 | |||||||||||||||||||
| measles | MEAS | MEAS | ||||||||||||||||||
| mumps | MUMPS | MUMPS | ||||||||||||||||||
| rubella | RUBE | RUBE | ||||||||||||||||||
| varicella | VAR9 | |||||||||||||||||||
| human papillomavirus infection | HPV (F/M)10 | |||||||||||||||||||
| influenza | IIV4 | IIV4/QIV-HD11 | ||||||||||||||||||
Version:
Footnotes:
- RSV vaccination recommended as free of charge for pregnant women in the 24-36 week of pregnancy
- RSV vaccination recommended to persons >60 years. Partial (50%) funding for persons 60-64 years old, free of charge for persons 65 years old and older.
- COVID-19 vaccinations recommended for indicated risk groups. For detailed information: https://pacjent.gov.pl/aktualnosc/zaszczep-sie-przeciw-covid-19-1
- Administration within 24 hours after birth or before the child is discharged from the hospital.
- Vaccine with the whole pertussis component (wP) used in the general population, vaccine with the acellular pertussis component (aP) used for children with contraindications to vaccination with the whole cell pertussis vaccine and in children born before 37th week of pregnancy or born with birth weight less than 2500 g.
- Vaccination for pregnant women in 27 and 36 week of pregnancy.
- PCV10 for whole population, PCV15 for children from risk groups.
- Men B and Men ACWY vaccines recommended and refunded only in risk groups for people aged 12 months - 18 years
- Varicella vaccination is mandatory only for people under 19 years of age from risk groups (with immune disorders), for people under 19 years of age in their environment and for children staying in orphanages and different nurseries and nursing and care facilities.
- HPV2 or HPV9 are available for the whole population aged 9-14 years; HPV2 is offered free of charge for children aged 9-18 years and for adults as partially funded (50%)(F/M).
- Recommended as a free vaccine for: children aged 6 months to 18 years, pregnant women, and older adults aged 65+; for individuals aged 19-64 years, a 50% refund. QIV_HD is recommended for individuals aged 60+ as partially funded (50%).
More information available at:
https://szczepienia.pzh.gov.pl/kalendarz-szczepien-2026/ https://dziennikmz.mz.gov.pl/DUM_MZ/2025/85/akt.pdf
_________________________________________________________________________
MAJOR HISTORICAL CHANGES
Measles, mumps and rubella:
1975: Measles vaccine was introduced into the national childhood vaccination schedule for children aged 13-15 months.
1989: Rubella vaccine (single dose) was introduced into the national childhood vaccination schedule for 13-year old girls.
1991: Second dose of measles vaccine was introduced into the national childhood vaccination schedule for children aged 7 years.
2003: Monovalent measles vaccine given at the age of 13-15 months was replaced by MMR
2005: Second dose of MMR was introduced into the national childhood vaccination schedule for children aged 10 years. An additional catch-up dose of MMR was provided during 2005-2008 at the age of 12 years for all girls not previously vaccinated at the age of 10 years.
2017: Pneumococcal vaccination introduced in the National Immunisation Programme
2020: Introduction of HPV Vaccine in girls and boys as part of the National Oncological Strategy
_________________________________________________________________________
Date of last update: 10 March 2026
_________________________________________________________________________